Showing results (971-980 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|March 8, 2016
A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteersAnhye Kim, Kyoung Soo Lim, Howard Lee, et al.International Clinical Psychopharmacology|November 10, 2015
Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophreniaShirley Rajan, Isheeta Zalpuri, Amy Harrington, et al.International Clinical Psychopharmacology|December 31, 2015
Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depressionJoseph Calabrese, Krithika Rajagopalan, Daisy Ng-Mak, et al.International Clinical Psychopharmacology|October 30, 2015
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in JapanTeruhiko Higuchi, Kunitoshi Kamijima, Kazuyuki Nakagome, et al.International Clinical Psychopharmacology|May 12, 2016
Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?Georgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, et al.International Clinical Psychopharmacology|June 9, 2016
Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics: a double-blind randomized placebo-controlled studyNam Wook Kim, Yul-Mai Song, Eosu Kim, et al.International Clinical Psychopharmacology|November 15, 2014
Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trialLeslie Citrome, Carl P Gommoll, Xiongwen Tang, et al.International Clinical Psychopharmacology|October 31, 2014
Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidoneSiegfried Kasper, Gino Montagnani, Graziella Trespi, et al.International Clinical Psychopharmacology|March 11, 2016
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory studyLeslie Citrome, Ai Ota, Kazuhiro Nagamizu, et al.International Clinical Psychopharmacology|August 1, 2015
Effectiveness of long-acting paliperidone palmitate in borderline personality disorderNerea Palomares, Ana Montes, Marina Díaz-Marsá, et al.Pageof 212